HOW IMPORTANT IS PLACEBO IN ANTIDEPRESSANT TRIALS?

HOW IMPORTANT IS PLACEBO IN ANTIDEPRESSANT TRIALS?

Bibliografski detalji
Glavni autor:	Cipriani, A
Format:	Conference item
Izdano:	2010

Slični predmeti

Impact of placebo arms on outcomes in antidepressant trials: systematic review and meta-regression analysis
od: Salanti, G, i dr.
Izdano: (2018)

Individual differences in response to antidepressants: a meta-analysis of placebo-controlled randomized clinical trials
od: Maslej, MM, i dr.
Izdano: (2021)

Antidepressants versus placebo for panic disorder in adults
od: Bighelli, I, i dr.
Izdano: (2018)

Efficacy of antidepressants over placebo is similar in two-armed versus three-armed or more-armed randomized placebo-controlled trials.
od: Ogawa, Y, i dr.
Izdano: (2017)

Brexpiprazole versus placebo or other antidepressive agents for treating depression
od: Ralovska, S, i dr.
Izdano: (2021)

Is placebo response in antidepressant trials rising or not? A reanalysis of datasets to conclude this long-lasting controversy.
od: Furukawa, T, i dr.
Izdano: (2018)

Disclosing the potential impact of placebo controls in antidepressant trials
od: Stephanie C. Chen, i dr.
Izdano: (2015-06-01)

Possibly no baseline severity effect for antidepressants versus placebo but for antipsychotics. Why?
od: Leucht, S, i dr.
Izdano: (2018)

Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies
od: Furukawa, T, i dr.
Izdano: (2016)

Neural Predictors of the Antidepressant Placebo Response
od: Danielle Rette, i dr.
Izdano: (2019-10-01)

"Wish bias" in antidepressant drug trials?
od: Barbui, C, i dr.
Izdano: (2004)

Development and validation of a prediction model for the probability of responding to placebo in antidepressant trials: a pooled analysis of individual patient data
od: Shinohara, K, i dr.
Izdano: (2019)

Comparative efficacy of placebos in short-term antidepressant trials for major depression: a secondary meta-analysis of placebo-controlled trials
od: Lisa Holper, i dr.
Izdano: (2020-09-01)

DSM-III-R change in definition might have affected placebo response to antidepressants - Authors' reply
od: Cipriani, A, i dr.
Izdano: (2017)

Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials.
od: Ludovic Trinquart, i dr.
Izdano: (2012-01-01)

Polygenic heterogeneity in antidepressant treatment and placebo response
od: Anne Krogh Nøhr, i dr.
Izdano: (2022-10-01)

Challenging Received Wisdom: Antidepressants and the Placebo Effect
od: Irving Kirsch
Izdano: (2020-12-01)

Neuroimaging Studies of Antidepressant Placebo Effects: Challenges and Opportunities
od: Vanessa Brown, i dr.
Izdano: (2019-09-01)

Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: Individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials
od: Noma, H, i dr.
Izdano: (2019)

Measuring brain glucose metabolism in order to predict response to antidepressant or placebo: A randomized clinical trial
od: Kathryn R. Hill, i dr.
Izdano: (2021-01-01)

Suicide, depression, and antidepressants.
od: Cipriani, A, i dr.
Izdano: (2005)

Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
od: Barnes, T, i dr.
Izdano: (2016)

Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
od: Thomas RE Barnes, i dr.
Izdano: (2016-04-01)

Expectancy-mood neural dynamics predict antidepressant placebo effects
od: Marta Pecina, i dr.
Izdano: (2025-01-01)

Significance of Participants’ Expectations in Managing the Placebo Effect in Antidepressant Research
od: Marko Curkovic, i dr.
Izdano: (2019-10-01)

The importance of using placebo controls in nonpharmacological randomised trials
od: Wartolowska, KA, i dr.
Izdano: (2022)

Ranking antidepressants Reply
od: Cipriani, A, i dr.
Izdano: (2009)

Raising Placebo Efficacy in Antidepressant Trials Across Decades Explained by Small-Study Effects: A Meta-Reanalysis
od: Lisa Holper
Izdano: (2020-07-01)

Antidepressants are an Important Part of Treating Depression
od: Jitender eSareen, i dr.
Izdano: (2012-07-01)

At what level of severity do we need antidepressive drugs?
od: Cipriani, A
Izdano: (2019)

Tricyclic antidepressants versus ‘active placebo’, placebo or no intervention for adults with major depressive disorder: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
od: Caroline Kamp Jørgensen, i dr.
Izdano: (2021-08-01)

Risk of suicidal behaviour in adults taking antidepressants.
od: Geddes, JR, i dr.
Izdano: (2009)

Risk of suicidal behaviour in adults taking antidepressants
od: Geddes, JR, i dr.
Izdano: (2009)

Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson’s disease
od: A Schrag, i dr.
Izdano: (2022-12-01)

Antidepressants in unipolar major depression: what we need to know
od: Barber, S, i dr.
Izdano: (2016)

Antidepressants – the trendy panacea but how safe are they?
Izdano: (2016-08-01)

Study protocol: combined N-of-1 trials to assess open-label placebo treatment for antidepressant discontinuation symptoms [FAB-study]
od: Amke Müller, i dr.
Izdano: (2023-10-01)

Antidepressants for bipolar disorder: A clinical overview of efficacy and safety
od: Cipriani, A, i dr.
Izdano: (2008)

Interindividual differences in anhedonia moderate antidepressant placebo responses on heart rate in healthy individuals
od: Li-Ching Chuang, i dr.
Izdano: (2024-01-01)

Placebos Are Part of the Solution, Not the Problem. An Exemplification of the Case of Antidepressants in Pediatric Chronic Pain Conditions
od: Cosima Locher, i dr.
Izdano: (2020-01-01)